Expand GPCR Menu
GPCR MENU

GPCR Stock Summary and Trading Ideas (Structure Therapeutics - American Depositary Shares | NASDAQ:GPCR)

Charts for Today's Stock Price and Implied Volatility in Structure Therapeutics - American Depositary Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for GPCR by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Structure Therapeutics - American Depositary Shares (GPCR) Frequently Asked Questions

What does Structure Therapeutics - American Depositary Shares do?

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

What symbol and exchange does Structure Therapeutics - American Depositary Shares shares trade?

Structure Therapeutics - American Depositary Shares trades on the NASDAQ stock market under the symbol GPCR.

What is Structure Therapeutics - American Depositary Shares stock price doing today?

As of June 3, 2026, GPCR stock price declined to $37.13 with 271,126 million shares trading.

What is Structure Therapeutics - American Depositary Shares's Beta?

GPCR has a beta of -0.18, meaning it tends to be less sensitive to market movements. GPCR has a correlation of 0.00 to the broad based SPY ETF.

How much is Structure Therapeutics - American Depositary Shares worth?

GPCR has a market cap of $2.64 billion. This is considered a Mid Cap stock.

How much money does Structure Therapeutics - American Depositary Shares make?

Last quarter Structure Therapeutics - American Depositary Shares reported $0 in Revenue and -$.35 earnings per share. This fell short of revenue expectation by $-11 million and missed earnings estimates by -$.02.

What is the highest and lowest price Structure Therapeutics - American Depositary Shares traded in the last 3 year period?

In the last 3 years, GPCR traded as high as $94.90 and as low as $13.22.

What are the top ETFs holding Structure Therapeutics - American Depositary Shares?

The top ETF exchange traded funds that GPCR belongs to (by Net Assets): IBB, FDG, SBIO, FFSM, EWX.

Is Structure Therapeutics - American Depositary Shares (GPCR) a good investment?

GPCR has outperformed the market in the last year with a price return of +70.4% while the SPY ETF gained +28.7%. However, in the short term, GPCR had mixed performance relative to the market. It has underperformed in the last 3 months, returning -41.0% vs +10.3% return in SPY. But in the last 2 weeks, GPCR shares have fared better than the market returning +3.5% compared to SPY +2.9%.

What are the support and resistance levels for Structure Therapeutics - American Depositary Shares (GPCR)?

GPCR support price is $35.89 and resistance is $38.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GPCR shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes